{"nct_id":"NCT06679582","title":"Luveltamab Tazevibulin (STRO-002) in Infants and Children < 12 Years of Age With Relapsed/Refractory CBFA2T3::GLIS2 AML","status":"TERMINATED","status_verified_date":"2024-11","start_date":"2024-12-04","start_date_type":"ACTUAL","primary_completion_date":"2025-06-01","primary_completion_date_type":"ACTUAL","completion_date":"2025-06-01","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["STRO"]}